Tectonic Therapeutic, Inc. Common Stock TECX
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-13T02:44:05.534Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T21:00:01.150024102Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T02:44:05.341182+00:00
Tectonic Therapeutic, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 16.79 | 394.7% | 31.9% | |||
| 30Δ | 18.24 | 327.1% | 24.9% | |||
| 35Δ | 19.44 | 273.4% | 19.2% | |||
| 40Δ | 20.31 | 234.6% | 15.2% | |||
| 45Δ | 22.38 | 167.7% | 13.6% | 20.88 | 208.6% | 12.6% |
| 50Δ | 21.72 | 167.8% | 11.9% | 21.46 | 182.6% | 9.9% |
| 55Δ | 21.06 | 167.8% | 10.2% | 22.03 | 156.7% | 7.3% |
| 60Δ | 20.40 | 167.8% | 8.5% | 23.05 | 138.7% | 5.1% |
| 65Δ | 19.81 | 163.3% | 6.9% | 26.14 | 157.7% | 4.4% |
| 70Δ | 19.33 | 152.1% | 5.7% | 29.22 | 176.7% | 3.8% |
| 75Δ | 18.84 | 140.8% | 4.4% | 32.31 | 195.7% | 3.1% |
| 80Δ | 18.36 | 129.5% | 3.2% | 35.39 | 214.7% | 2.5% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 16.79
- IV
- 394.7%
- B/E move
- 31.9%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 18.24
- IV
- 327.1%
- B/E move
- 24.9%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 19.44
- IV
- 273.4%
- B/E move
- 19.2%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 20.31
- IV
- 234.6%
- B/E move
- 15.2%
45Δ
- Pseudo strike
- 22.38
- IV
- 167.7%
- B/E move
- 13.6%
- Pseudo strike
- 20.88
- IV
- 208.6%
- B/E move
- 12.6%
50Δ
- Pseudo strike
- 21.72
- IV
- 167.8%
- B/E move
- 11.9%
- Pseudo strike
- 21.46
- IV
- 182.6%
- B/E move
- 9.9%
55Δ
- Pseudo strike
- 21.06
- IV
- 167.8%
- B/E move
- 10.2%
- Pseudo strike
- 22.03
- IV
- 156.7%
- B/E move
- 7.3%
60Δ
- Pseudo strike
- 20.40
- IV
- 167.8%
- B/E move
- 8.5%
- Pseudo strike
- 23.05
- IV
- 138.7%
- B/E move
- 5.1%
65Δ
- Pseudo strike
- 19.81
- IV
- 163.3%
- B/E move
- 6.9%
- Pseudo strike
- 26.14
- IV
- 157.7%
- B/E move
- 4.4%
70Δ
- Pseudo strike
- 19.33
- IV
- 152.1%
- B/E move
- 5.7%
- Pseudo strike
- 29.22
- IV
- 176.7%
- B/E move
- 3.8%
75Δ
- Pseudo strike
- 18.84
- IV
- 140.8%
- B/E move
- 4.4%
- Pseudo strike
- 32.31
- IV
- 195.7%
- B/E move
- 3.1%
80Δ
- Pseudo strike
- 18.36
- IV
- 129.5%
- B/E move
- 3.2%
- Pseudo strike
- 35.39
- IV
- 214.7%
- B/E move
- 2.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 132.52% | |
| 134.73% | |
| 131.16% | |
| 133.39% | |
| 140.27% | |
| 139.85% | |
| 148.12% | |
| 144.71% | |
| 139.68% | |
| 137.16% |
Biotechnology
TENX
Description unavailable
More →TGTX
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and…
More →TNGX
Description unavailable
More →TNXP
Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey.
More →TNYA
Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary engineered heart cell…
More →TRAX
First Tracks Biotherapeutics (Ticker: TRAX) is a forward-thinking biotechnology company focused on developing targeted therapeutics for chronic diseases, utilizing advanced…
More →